|
2
Votes
vote
China SFDA awards Jiangsu Yanshen a new drug certificate and production license for its H1N1 vaccineSimcere Pharmaceutical Group (NYSE: SCR) ("Simcere" or the "Company"), a leading manufacturer and supplier of branded generic and innovative pharmaceuticals in China, today announced that Jiangsu Yanshen Biological Technology Stock Co., Ltd ("Jiangsu Yanshen"), in wh... |

